SHENZHEN, China--(BUSINESS WIRE)--Tongjitang Chinese Medicines Company (NYSE: TCM), a leading specialty pharmaceutical company focusing on the development, manufacture, marketing and sale of modernized traditional Chinese medicine in China, announced that effective June 16, 2009, it has changed its independent auditor for the year ending December 31, 2009 from Deloitte Touche Tohmatsu (“Deloitte”) to Ernst & Young Hua Ming. Deloitte audited Tongjitang’s financial statements for each of the previous five years. The change was approved by Tongjitang’s audit committee and full board of directors.
